Press Releases

All Releases
View Summary Synageva BioPharma to Present at the Nomura Biotechnology Conference
Oct 29, 2014
PDF 19.5 KB
View Summary Synageva BioPharma Presents Sebelipase Alfa Data At The NASPGHAN Meeting
Oct 23, 2014
PDF 27.7 KB
View Summary Synageva BioPharma Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa
Oct 21, 2014
PDF 24.2 KB
View Summary Sebelipase Alfa Phase 3 Data In Children And Adults With LAL Deficiency Selected For Oral Presentation During The Late-Breaking Session At The Liver Meeting®
Oct 8, 2014
PDF 24.1 KB
View Summary Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer
Sep 22, 2014
PDF 23.3 KB
View Summary Synageva BioPharma To Present At The Morgan Stanley Global Healthcare Conference
Sep 2, 2014
PDF 19.8 KB
View Summary Synageva BioPharma™ To Present At The Baird 2014 Healthcare Conference
Aug 26, 2014
PDF 21.4 KB
View Summary Synageva BioPharma™ To Present At Upcoming Investor Conferences
Aug 4, 2014
PDF 21.5 KB
View Summary Synageva BioPharma™ Reports Second Quarter 2014 Financial Results
Jul 30, 2014
PDF 31.1 KB
View Summary Synageva BioPharma™ Reports Positive Top-Line Results From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency
Jun 30, 2014
PDF 26.7 KB
View Summary Synageva BioPharma™ Highlights Data Presentations And Satellite Symposium At The European Atherosclerosis Society Congress
Jun 3, 2014
PDF 26.3 KB
View Summary Synageva Biopharma™ To Present At The Jefferies And Goldman Sachs Healthcare Conferences
May 28, 2014
PDF 106.6 KB
View Summary Synageva BioPharma™ Announces Satellite Symposium at the National Lipid Association Meeting
May 2, 2014
PDF 26.2 KB
View Summary Synageva BioPharma™ Reports First Quarter 2014 Financial Results
Apr 30, 2014
PDF 31.4 KB
View Summary LAL Deficiency Disease Review Published in Atherosclerosis
Apr 21, 2014
PDF 27.3 KB
View Summary Synageva Biopharma Announces Pricing of Public Offering of Common Stock
Mar 5, 2014
PDF 23.1 KB
View Summary Synageva Biopharma™ Announces a 2.00 Million Share Proposed Public Offering of Its Common Stock
Mar 4, 2014
PDF 22.8 KB
View Summary Synageva BioPharma™ Issued U.S. Patent for Treatment of LAL Deficiency
Mar 4, 2014
PDF 26.4 KB
View Summary Synageva BioPharma™ Reports 2013 Full Year Financial Results
Mar 3, 2014
PDF 35.8 KB
View Summary Synageva BioPharma™ Joins NORD, EURORDIS, and The Global Genes Project in Support of Rare Disease Day 2014
Feb 28, 2014
PDF 30.3 KB
Showing 1-20 of 115 Page: 1 2 3 4 5 6  Next 20